Episode 53: Frank David, Founder and Managing Director, Pharmagellan

Update: 2025-04-29

Description

How do mission, vision, and data analysis fit into today's biotech goals?

Host Chris O'Brien welcomes Frank David, Founder and Managing Director of Pharmagellan to the podcast. Tune in as we explore R&D strategy, de-risking tactics, and how to think about valuation.

Listen in to the latest episode of the Biorasi Few & Far Between podcast today!

Comments

In Channel

Episode 59, Part One: Yochi Slonim, Co-Founder and CEO at Anima Biotech

2025-09-0343:41

Episode 58: Jerry McLaughlin, CEO and Board Member at Life Biosciences

2025-08-1444:43

Episode 57: Jim Brown, DVM, President and CEO of DURECT Corporation

2025-07-2244:53

Episode 56, Part Two: Michael Tolentino, MD, Co-Founder and Head Scientific Consultant, Aviceda Therapeutics

2025-07-1539:28

Episode 55: Julio G. Martinez-Clark, CEO and Co-Founder at bioaccess®

2025-07-0938:46

Episode 54, Part One: Michael Tolentino, MD, Co-Founder and Head Scientific Consultant, Aviceda Therapeutics

2025-05-2845:11

Episode 53: Frank David, Founder and Managing Director, Pharmagellan

2025-04-2950:46

Episode 52: Joshua Kresh, Emily Michiko Morris, and Mark Schultz, IPPI

2025-04-2352:05

Episode 51: Dan Oliver, CEO and Founder, Rejuvenate Bio

2025-04-0355:05

Epsiode 50: Jonathan Rigby, Chairman and CEO, Sernova

2025-03-1852:02

Episode 49: Eileen Faucher, Principal and Founder, Brass Tacks Health

2025-02-2735:37

Episode 48: John Celebi, President and CEO, Sensei Bio

2025-02-1838:46

Episode 46: Ben Olds and Amy Fenollosa, Haven Human Asset Ventures

2025-01-1543:29

Episode 47 - Marc Lajoie, CEO at Outpace Bio

2024-12-3148:25

Episode 46: Dr. Carsten Rudolph, CEO and Managing Director at Ethris

2024-12-1237:26

Episode 44: Jonathan Scheiman, PhD, Co-Founder and CEO at FitBiomics

2024-10-2344:29

Episode 43: Isaac Stoner, Co-founder and CEO at Octagon Therapeutics

2024-09-1239:18

Episode 42: Diana Azzam, PhD, Assistant Professor at Florida International University, Co-Founder at First Ascent Biomedical

2024-07-1636:14

Episode 41: Craig Serra, Head of Clinical Research Scientific and Technical Engagement, Flatiron Health

2024-05-2335:24

Episode 40: Professor Justin Stebbing, Editor-in-Chief, Oncogene journal

2024-04-2533:23

00:00

Episode 53: Frank David, Founder and Managing Director, Pharmagellan

#box-pro-ellipsis-175765834989934{-webkit-line-clamp:2;}Episode 53: Frank David, Founder and Managing Director, Pharmagellan

Episode 53: Frank David, Founder and Managing Director, Pharmagellan

Chris O&#39;Brien

Episode 53: Frank David, Founder and Managing Director, Pharmagellan

Chris O'Brien